[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Stem Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type, By Therapeutic Application (Oncology, Cardiovascular Disease, Musculoskeletal Disorders), By Region, And Segment Forecasts, 2024 - 2030

May 2024 | 100 pages | ID: SECE36102F7CEN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 2 Business Days

Stem Cell Therapy Market Growth & Trends

The global stem cell therapy market size is anticipated to reach USD 1,670.1 million by 2030 and is projected to grow at a CAGR of 24.15% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is propelled by several key factors that underscore both scientific advancements and evolving healthcare needs.Advancements in stem cell research and technology have revolutionized the landscape of regenerative medicine. Breakthroughs in stem cell isolation, characterization, and manipulation techniques have empowered researchers to harness the therapeutic potential of stem cells with greater precision and efficacy. For instance, in May 2023, EPROCELL introduced Contract Development and Manufacturing Organization (CDMO) services for producing Advanced Therapies Medicinal Products (ATMPs) derived from mesenchymal stem cells (MSC). This expansion is facilitated by a partnership with Histocell. These advancements have spurred the development of innovative therapies targeting a wide spe

trum of medical conditions, from chronic diseases to degenerative disorders.

The increasing prevalence of chronic and degenerative diseases has fueled the demand for novel treatment modalities. Conditions such as cardiovascular diseases, neurodegenerative disorders, orthopedic injuries, and autoimmune diseases pose significant healthcare challenges, driving the search for innovative therapeutic approaches. For instance, a study published in The Lancet Neurology has anticipated a significant increase in the number of individuals affected by Parkinson's disease by the year 2040. The projected figure is alarming, as it suggests that the number of people living with this neurodegenerative disorder may double, reaching at least 12.9 million worldwide. Stem cell therapies hold immense promise in addressing these complex diseases by promoting tissue regeneration, modulating immune responses, and restoring organ function, thus offering new avenues for disease management and treatment.

Investment in the global market has been steadily increasing as investors recognize the potential for groundbreaking medical advancements and lucrative returns. This influx of capital fuels research, development, and commercialization efforts, driving the overall market growth. With a growing emphasis on regenerative medicine and personalized healthcare, the market is poised for continued expansion, offering innovative treatments and renewed hope to patients grappling with a wide range of medical conditions.

Stem Cell Therapy Market Report Highlights
  • Based on therapy type, the allogeneic stem cell therapies segment led the market with the largest revenue share of 68.41% by 2023 and is anticipated to grow at the fastest CAGR of 26.74% during the forecast period, propelled by a convergence of factors contributing to its expansion.such as increasing landscape of research and clinical trials within the field
  • Based on therapeutic application, the other therapeutic segment including diseases such as blood disorders, and neurological disorders led the market with the largest revenue share of 72.75% in 2023, fueled by ongoing research and clinical advancements
  • North America dominated the market with the largest revenue share of 50.11% in 2023 and is anticipated to grow at the fastest CAGR of 28.07% during the forecast period, driven by several key factors. The market growth is facilitated by favorable regulatory frameworks, rising rates of chronic diseases, and technological improvements
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation and Scope
1.2. Market Definitions
  1.2.1. Therapy Type
  1.2.2. Therapeutic Application
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
  1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE

3.1. Market Lineage Outlook
  3.1.1. Parent Market Outlook
  3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
  3.2.1. Market Driver Analysis
    3.2.1.1. Growing research & development in stem cell therapy
    3.2.1.2. Increasing prevalence of chronic diseases
    3.2.1.3. Technological advancements
  3.2.2. Market Restraint Analysis
    3.2.2.1. High cost of stem cell therapy
3.3. Industry Analysis Tools
  3.3.1. Porter's Five Forces Analysis
  3.3.2. PESTEL Analysis
  3.3.3. COVID-19 Impact Analysis

CHAPTER 4. STEM CELL THERAPY MARKET: THERAPY TYPE BUSINESS ANALYSIS

4.1. Segment Dashboard
4.2. Global Stem Cell Therapy Market Therapy Type Movement Analysis
4.3. Global Stem Cell Therapy Market Size & Trend Analysis, by Therapy Type, 2018 to 2030 (USD Million)
4.4. Allogeneic Stem Cell Therapies
  4.4.1. Global Allogeneic Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4.2. Hematopoietic Stem Cell Therapies
    4.4.2.1. Global Hematopoietic Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4.3. Mesenchymal Stem Cell Therapies
    4.4.3.1. Global Mesenchymal Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Autologous Stem Cell Therapies, by Type
  4.5.1. Global Autologous Stem Cell Therapies, by Type Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.5.2. BM, Blood, & Umbilical Cord-derived Stem Cells
    4.5.2.1. Global BM, Blood, & Umbilical Cord-derived Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.5.3. Adipose-Derived Cells
    4.5.3.1. Global Adipose-Derived Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.5.4. Others
    4.5.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 5. STEM CELL THERAPY MARKET: THERAPEUTIC APPLICATION BUSINESS ANALYSIS

5.1. Segment Dashboard
5.2. Global Stem Cell Therapy Market Therapeutic Application, Movement Analysis
5.3. Global Stem Cell Therapy Market Size & Trend Analysis, by Therapeutic Application, 2018 to 2030 (USD Million)
5.4. Oncology
  5.4.1. Global Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Cardiovascular Disease (CVD)
  5.5.1. Global Cardiovascular Disease (CVD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Musculoskeletal Disorders
  5.6.1. Global Musculoskeletal Disorders Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
  5.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 6. STEM CELL THERAPY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY THERAPY TYPE, AND THERAPEUTIC APPLICATION

6.1. Regional Dashboard
6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.3. North America
  6.3.1. North America Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.2. U.S.
    6.3.2.1. Key Country Dynamics
    6.3.2.2. Competitive Scenario
    6.3.2.3. Regulatory Framework
    6.3.2.4. U.S. Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.3. Canada
    6.3.3.1. Key Country Dynamics
    6.3.3.2. Competitive Scenario
    6.3.3.3. Regulatory Framework
    6.3.3.4. Canada Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Europe
  6.4.1. Europe Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.2. UK
    6.4.2.1. Key Country Dynamics
    6.4.2.2. Competitive Scenario
    6.4.2.3. Regulatory Framework
    6.4.2.4. UK Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.3. Germany
    6.4.3.1. Key Country Dynamics
    6.4.3.2. Competitive Scenario
    6.4.3.3. Regulatory Framework
    6.4.3.4. Germany Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4.4. Switzerland
    6.4.4.1. Key Country Dynamics
    6.4.4.2. Competitive Scenario
    6.4.4.3. Regulatory Framework
    6.4.4.4. Switzerland Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Asia Pacific
  6.5.1. Asia Pacific Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5.2. Japan
    6.5.2.1. Key Country Dynamics
    6.5.2.2. Competitive Scenario
    6.5.2.3. Regulatory Framework
    6.5.2.4. Japan Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5.3. China
    6.5.3.1. Key Country Dynamics
    6.5.3.2. Competitive Scenario
    6.5.3.3. Regulatory Framework
    6.5.3.4. China Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5.4. India
    6.5.4.1. Key Country Dynamics
    6.5.4.2. Competitive Scenario
    6.5.4.3. Regulatory Framework
    6.5.4.4. India Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5.5. South Korea
    6.5.5.1. Key Country Dynamics
    6.5.5.2. Competitive Scenario
    6.5.5.3. Regulatory Framework
    6.5.5.4. South Korea Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Rest of World
  6.6.1. Rest of World Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 7. COMPETITIVE LANDSCAPE

7.1. Participant Categorization
7.2. Strategy Mapping
7.3. Company Market Position Analysis, 2023
7.4. Participant’s Overview
  7.4.1. Bluebird Bio, Inc.
    7.4.1.1. Overview
    7.4.1.2. Financial Performance
    7.4.1.3. Product Benchmarking
    7.4.1.4. Strategic Initiatives
  7.4.2. NIPRO
    7.4.2.1. Overview
    7.4.2.2. Financial Performance
    7.4.2.3. Product Benchmarking
    7.4.2.4. Strategic Initiatives
  7.4.3. Orchard Therapeutics plc
    7.4.3.1. Overview
    7.4.3.2. Financial Performance
    7.4.3.3. Product Benchmarking
    7.4.3.4. Strategic Initiatives
  7.4.4. Pharmicell Co., Ltd.
    7.4.4.1. Overview
    7.4.4.2. Financial Performance
    7.4.4.3. Product Benchmarking
    7.4.4.4. Strategic Initiatives
  7.4.5. CorestemChemon Inc.
    7.4.5.1. Overview
    7.4.5.2. Financial Performance
    7.4.5.3. Product Benchmarking
    7.4.5.4. Strategic Initiatives
  7.4.6. ANTEROGEN.CO.,LTD.
    7.4.6.1. Overview
    7.4.6.2. Financial Performance
    7.4.6.3. Product Benchmarking
    7.4.6.4. Strategic Initiatives
  7.4.7. Holostem S.r.l.
    7.4.7.1. Overview
    7.4.7.2. Financial Performance
    7.4.7.3. Product Benchmarking
    7.4.7.4. Strategic Initiatives
  7.4.8. Vertex Pharmaceuticals, Inc.
    7.4.8.1. Overview
    7.4.8.2. Financial Performance
    7.4.8.3. Product Benchmarking
    7.4.8.4. Strategic Initiatives
  7.4.9. Cleveland Cord Blood Center
    7.4.9.1. Overview
    7.4.9.2. Financial Performance
    7.4.9.3. Product Benchmarking
    7.4.9.4. Strategic Initiatives
  7.4.10. Gamida Cell Ltd.
    7.4.10.1. Overview
    7.4.10.2. Financial Performance
    7.4.10.3. Product Benchmarking
    7.4.10.4. Strategic Initiatives
LIST OF TABLES


Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 4 Global stem cell therapy market, by application, 2018 - 2030 (USD Million)
Table 5 Global stem cell therapy market, by region, 2018 - 2030 (USD Million)
Table 6 North America stem cell therapy market, by country, 2018 - 2030 (USD Million)
Table 7 North America stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 8 North America stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 9 U.S. stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 10 U.S. stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 11 U.S. stem cell therapy market, by end-use, 2018 - 2030 (USD Million)
Table 12 Canada stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 13 Canada stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 14 Europe stem cell therapy market, by country, 2018 - 2030 (USD Million)
Table 15 Europe stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 16 Europe stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 17 UK stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 18 UK stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 19 Germany stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 20 Germany stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 21 Switzerland stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 22 Switzerland stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 23 Asia Pacific stem cell therapy market, by country, 2018 - 2030 (USD Million)
Table 24 Asia Pacific stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 25 Asia Pacific stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 26 Japan stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 27 Japan stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 28 China stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 29 China stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 30 India stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 31 India stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 32 South Korea stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 33 South Korea stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 34 Rest of World stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 35 Rest of World stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 36 Participant's overview
Table 37 Financial performance
Table 38 Key companies undergoing expansions
Table 39 Key companies undergoing acquisitions
Table 40 Key companies undergoing collaborations
Table 41 Key companies launching new products
Table 42 Key companies undertaking other strategies
LIST OF FIGURES


Fig. 1 Stem cell therapy market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Parent market outlook
Fig. 11 Stem cell therapy market driver analysis
Fig. 12 Stem cell therapy market restraint analysis
Fig. 13 Stem cell therapy market: Porter's analysis
Fig. 14 Stem cell therapy market: PESTEL analysis
Fig. 15 Stem cell therapy market: Therapy type outlook and key takeaways
Fig. 16 Stem cell therapy market: Therapy type market share analysis, 2023 - 2030
Fig. 17 Global stem cell therapy by allogeneic stem cell therapies market, 2018 - 2030 (USD Million)
Fig. 18 Global stem cell therapy by hematopoietic stem cell therapies market, 2018 - 2030 (USD Million)
Fig. 19 Global stem cell therapy by mesenchymal stem cell therapies market, 2018 - 2030 (USD Million)
Fig. 20 Global stem cell therapy by autologous stem cell therapies market, 2018 - 2030 (USD Million)
Fig. 21 Global stem cell therapy by BM, blood, & umbilical cord-derived stem cells market, 2018 - 2030 (USD Million)
Fig. 22 Global stem cell therapy by adipose derived cells market, 2018 - 2030 (USD Million)
Fig. 23 Global stem cell therapy by others market, 2018 - 2030 (USD Million)
Fig. 24 Stem cell therapy market: Therapeutical application outlook and key takeaways
Fig. 25 Stem cell therapy market: Therapeutical application market share analysis, 2023-2030
Fig. 26 Global stem cell therapy by oncology market, 2018 - 2030 (USD Million)
Fig. 27 Global stem cell therapy by cardiovascular disease (CVD) market, 2018 - 2030 (USD Million)
Fig. 28 Global stem cell therapy by musculoskeletal disorders market, 2018 - 2030 (USD Million)
Fig. 29 Global stem cell therapy by other market, 2018 - 2030 (USD Million)
Fig. 30 Regional marketplace: Key takeaways
Fig. 31 North America stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 U.S. stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Canada stem cell therapy market, 2018 - 2030 (USD Million)
Fig. 34 Europe stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 UK stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Germany stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Switzerland stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Asia-Pacific stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Japan stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 China stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 India stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 South Korea stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Rest of World stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Key company categorization
Fig. 45 Company market positioning
Fig. 46 Market participant categorization
Fig. 47 Strategy framework


More Publications